ANTICOAGULANT treatment is winning for itself a firm place in the armamentarium against postoperative venous thrombosis and pulmonary embolism. This has been accomplished by the sheer weight of ...
6d
News Medical on MSNEvaluating the safety and efficacy of Tendvia mechanical thrombectomy for acute pulmonary embolismAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE).
Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the momentum of treatment once initiated.
Acute pulmonary embolism is rare during childhood and adolescence. The high pulmonary embolism-related fatality among ...
Hosted on MSN17d
Premature ejaculation treatment market to grow by $1.53b by 2029The global premature ejaculation (PE) treatment market is projected to grow by $1.53b by 2029 at a compound annual growth rate of 8.6%, according to Technavio. The sector’s expansion is driven ...
"I am incredibly excited to be involved in this study as it represents a significant milestone in the forward trajectory of pulmonary embolism treatment." ...
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
"I am incredibly excited to be involved in this study as it represents a significant milestone in the forward trajectory of pulmonary embolism treatment." The QUADRA-PE study is a multi-center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results